Capricor: DMD Treatment Focus With Deramiocel Is Likely To Pay Off

Core Viewpoint - Capricor Therapeutics, Inc. plans to file a Biologics License Application (BLA) for deramiocel aimed at treating patients with Duchenne Muscular Dystrophy (DMD) cardiomyopathy [2] Company Summary - Capricor Therapeutics is advancing its product deramiocel for DMD cardiomyopathy, indicating progress in its clinical development [2]